LIGHTON 4.330 € (-2,26 %) FERMENTALG 0.486 € (-1,02 %) 
CVC CAPITAL 12.720 € (-0,55 %) ODYSSEE TECHNO 21.100 € (-0,47 %) VIRIDIEN 113.000 € (+1,07 %) HAFFNER ENERGY 0.249 € (+10,44 %) AIR LIQUIDE 165.780 € (-9,61 %) STIF 56.800 € (-0,35 %) UNIBAIL-RODAMCO-WE 97.580 € (-0,22 %) ESSILORLUXOTTICA 171.900 € (-1,24 %) LEGRAND 142.200 € (-1,25 %) PUBLICIS GROUPE SA 86.960 € (-0,55 %) PROSUS 39.685 € (-1,16 %) SARTORIUS STED BIO 175.400 € (-1,96 %) AMG 35.440 € (-2,90 %) EUROFINS SCIENT. 64.140 € (-1,20 %) 
DSM FIRMENICH AG 66.660 € (-1,88 %) SCHNEIDER ELECTRIC 266.100 € (-1,10 %) UMG 18.220 € (+0,39 %) GECINA 71.150 € (-0,63 %) 
UNILEVER 48.350 € (-0,53 %) COVIVIO 53.150 € (-0,56 %) AXA 39.600 € (+0,20 %) LINEDATA SERVICES 41.100 € (+0,49 %) ASML HOLDING 1 452.000 € (-0,70 %) NANOBIOTIX 30.740 € (-0,71 %) SANOFI 77.570 € (-0,49 %) SIGNIFY NV 20.520 € (-2,10 %) FDJ UNITED 22.630 € (-0,35 %) KLEPIERRE 35.000 € (+0,86 %) CSG 14.896 € (+0,07 %) BNP PARIBAS ACT.A 92.750 € (-0,96 %) CAPGEMINI 101.300 € (-0,49 %) VALEO 15.005 € (-0,76 %) DASSAULT SYSTEMES 19.780 € (+0,33 %) L'OREAL 375.000 € (-0,13 %) DERICHEBOURG 10.060 € (+0,30 %) REXEL 36.180 € (-1,44 %) METROPOLE TV 12.260 € (+6,79 %) LVMH 474.600 € (-0,93 %) TOTALENERGIES 78.250 € (+1,14 %) MAGNUM 14.832 € (-0,07 %) BIOMERIEUX 71.550 € (-1,78 %) SAINT GOBAIN 73.860 € (-4,40 %) AIRBUS 174.580 € (-2,45 %) ASM INTERNATIONAL 847.400 € (-2,26 %) SOITEC 155.700 € (+6,17 %) KERING 245.300 € (-1,66 %) SOCIETE GENERALE 69.540 € (-1,02 %) ORANGE 17.755 € (+1,84 %) 2CRSI 50.850 € (+2,23 %) ADYEN 833.400 € (+1,96 %) TECHNIP ENERGIES 35.240 € (+0,69 %) 
EDP RENEWABLES 13.960 € (-0,50 %) DANONE 64.540 € (+0,19 %) SHELL PLC 37.700 € (+0,82 %) STMICROELECTRONICS 63.340 € (+0,83 %) ST DUPONT 0.086 € (-0,23 %) EKINOPS 2.985 € (-4,78 %) CRCAM BRIE PIC2CCI 42.200 € (+1,61 %) |
07/06/2026 21:24
EQS-Adhoc: Readcrest Capital AG: Management Board issues forecast for adjusted EBITDA in 2026EQS-Ad-hoc: Readcrest Capital AG / Key word(s): Forecast / Full year Disclosure of Inside Information pursuant to Article 17 of Regulation (EU) No. 596/2014 Readcrest Capital AG: Management Board issues forecast for adjusted EBITDA in 2026 Hamburg, June 7, 2026 – The Management Board of Readcrest Capital AG (“Company”, ISIN DE000A0LE3J1; WKN A0LE3J) expects adjusted EBITDA* for the current fiscal year 2026 to range from EUR 8.0 million to EUR 9.0 million. (This is composed as follows: an EBITDA contribution from Grosvenor Health and Social Care of approximately EUR 12 million, less the earnings contribution from German project developments of approximately EUR 3–4 million). The forecast takes into account the Group’s adjusted structure following the sale of the UK care home business. Grosvenor Health and Social Care, which remains in the portfolio, continues to form the basis for operating revenue and cash flow. In addition, the company is systematically expanding its second growth pillar—value-oriented real estate investments with a focus on promising residential construction projects in high-growth regions of Germany. Contact * Adjusted EBITDA is an unaudited financial metric not defined under IFRS: operating profit plus depreciation and amortization, adjusted for significant non-recurring items (e.g., adding impairment losses on receivables/inventory, deducting gains from the write-off of liabilities) and excluding the sold care homes. These adjustments isolate the underlying operating profitability.
End of Inside Information 07-Jun-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2340938 07-Jun-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière